Reena Rao1. 1. The Kidney Institute, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA. rrao@kumc.edu
Abstract
PURPOSE OF REVIEW: Glycogen synthase kinase-3 (GSK3) is an enzyme that is gaining prominence as a critical signaling molecule in the epithelial cells of renal tubules. This review will focus on recent findings exploring the role of GSK3 in renal collecting ducts, especially its role in urine concentration involving vasopressin signaling. RECENT FINDINGS: Recent studies using inhibition or tissue-specific gene deletion of GSK3 revealed the mechanism by which GSK3 regulates aquaporin 2 water channels via adenylate cyclase or the prostaglandin-E2 pathway. In other studies, postnatal treatment with lithium, an inhibitor of GSK3, increased cell proliferation and led to microcyst formation in rat kidneys. These studies suggest that loss of GSK3 activity could interfere with renal water transport at two levels. In the short term, it could disrupt vasopressin signaling in collecting duct cells and in the long term it could alter the structure of the collecting ducts, making them less responsive to the hydro-osmotic effects of vasopressin. SUMMARY: Ongoing studies reveal the crucial role played by GSK3 in the regulation of vasopressin action in the renal collecting ducts and suggest a possible use of GSK3 inhibitors in disease conditions associated with disrupted vasopressin signaling.
PURPOSE OF REVIEW: Glycogen synthase kinase-3 (GSK3) is an enzyme that is gaining prominence as a critical signaling molecule in the epithelial cells of renal tubules. This review will focus on recent findings exploring the role of GSK3 in renal collecting ducts, especially its role in urine concentration involving vasopressin signaling. RECENT FINDINGS: Recent studies using inhibition or tissue-specific gene deletion of GSK3 revealed the mechanism by which GSK3 regulates aquaporin 2water channels via adenylate cyclase or the prostaglandin-E2 pathway. In other studies, postnatal treatment with lithium, an inhibitor of GSK3, increased cell proliferation and led to microcyst formation in rat kidneys. These studies suggest that loss of GSK3 activity could interfere with renal water transport at two levels. In the short term, it could disrupt vasopressin signaling in collecting duct cells and in the long term it could alter the structure of the collecting ducts, making them less responsive to the hydro-osmotic effects of vasopressin. SUMMARY: Ongoing studies reveal the crucial role played by GSK3 in the regulation of vasopressin action in the renal collecting ducts and suggest a possible use of GSK3 inhibitors in disease conditions associated with disrupted vasopressin signaling.
Authors: Reena Rao; Ming-Zhi Zhang; Min Zhao; Hui Cai; Raymond C Harris; Matthew D Breyer; Chuan-Ming Hao Journal: Am J Physiol Renal Physiol Date: 2004-12-07
Authors: Rikke Nørregaard; Shixin Tao; Line Nilsson; James R Woodgett; Vijayakumar Kakade; Alan S L Yu; Christiana Howard; Reena Rao Journal: Am J Physiol Renal Physiol Date: 2015-01-21
Authors: Akshay Sanghi; Matthew Zaringhalam; Callan C Corcoran; Fahad Saeed; Jason D Hoffert; Pablo Sandoval; Trairak Pisitkun; Mark A Knepper Journal: Am J Physiol Renal Physiol Date: 2014-07-23
Authors: Janusz K Rybakowski; Maria Abramowicz; Aleksandra Szczepankiewicz; Michal Michalak; Joanna Hauser; Stanislaw Czekalski Journal: Int J Bipolar Disord Date: 2013-06-20
Authors: Grazia Tamma; Domenica Lasorsa; Christiane Trimpert; Marianna Ranieri; Annarita Di Mise; Maria Grazia Mola; Lisa Mastrofrancesco; Olivier Devuyst; Maria Svelto; Peter M T Deen; Giovanna Valenti Journal: J Am Soc Nephrol Date: 2014-04-03 Impact factor: 10.121
Authors: Jae H Sim; Nathaniel J Himmel; Sara K Redd; Fadi E Pulous; Richard T Rogers; Lauren N Black; Seongun M Hong; Tobias N von Bergen; Mitsi A Blount Journal: PLoS One Date: 2014-07-09 Impact factor: 3.240